pegaferon
PEGAFERON® 180 MCG
Iran and Middle East
OFFER
Company name:
pooyeshdarou
Field of Technology:

Medical Science

Environmental Aspects:

Yes

Development Phase:

Growth stage

Technical Specification:

Pegaferon® (Peginterferon alfa-2a) is a recombinant human protein (MW 19 kDa) conjugated to monomethoxy polyethylene glycol (PEG) for a total MW of about 60 kDa. Interferon alfa-2a is produced biosynthetically using recombinant DNA technology and is the product of a cloned human leukocyte interferon gene inserted into and expressed in E coli. Purified IFN has 165 amino acids and a molecular mass of 19237.

Benefit:

All activities are performed in a full cGMP environment, meeting the highest international quality standards. Pooyesh Darou sterile manufacturing facility includes an 11000 sq. ft. production site. Our aseptic fill and finish manufacturing facilities are capable of filing over 13 million low volume parenteral sterile unit per year and utilizes five high-speed filling lines and two lyophilizers.

After-Sales Services:

Yes

Country of Residence
City of Residence

Tehran

Target Country:

Iran and Middle East

Email:

info@pooyeshdarou.com

Website:

pooyeshdarou.com

Landline Telephone:

+98 21 88 997 248

Address:

NO. 13, 5th Ave, Fatemi St, Tehran, Iran